Found "Health Promotion": 1,004 results
Budgeting and paying for services under Thailand’s Universal Coverage Scheme
Health financing is a component of the health system, crucial in achieving universal health coverage (UHC). Careful design of its three main functions, resource mobilisation, pooling and allocation, ensures improved access to essential health services and financial risk protection for
Evaluating the Value of a Real-World HTA Agency
As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about
Which investment on interventions against COVID-19 pandemic is worth its cost?
Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted
Unpacking Digital Health: A breakdown of concepts and definitions
Digital health is an umbrella term that includes all healthcare services that are provided by ICT. From one’s personal wearable devices to the use of big data and AI in healthcare come under digital health’
Under the umbrella of digital health technology, various sub-groups such as electronic
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed.
The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro
English Policy Brief Collection – Volume 1
The English Policy Brief Collection (Volume 1) presents a selection of policy briefs published by the HITAP Foundation. These policy briefs have been categorized under the following key topics:
Chapter 1: Designing Universal Health Coverage (UHC) and Healthcare Systems
Chapter 2: Managing Rare
Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?
Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los
Early HTA: A Guide for Developing Pulmonary Tuberculosis Cost-Effective Tests Fitting the Healthcare Needs
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and represents a significant global health concern. Infectious agents can be easily spread through respiratory droplets, and TB patients face a significant risk of mortality.
The traditional sputum-based TB
Towards A Sustainable Kidney Replacement Therapy Program: Recommendations For Thailand’s 2022 Dialysis Reform
The National Health Security Office Working Group (NHSO WG) conducted structured, evidence-based deliberations to generate recommendations for the National Health Security Board on the kidney replacement therapy (KRT) policy.
These are the proposed recommendations:
To consider defining KRT p
The Life Saving Drug Program: Australia’s pathway to high-cost drugs
Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceuti
10 / Page